0001140361-11-020724.txt : 20110405
0001140361-11-020724.hdr.sgml : 20110405
20110405093320
ACCESSION NUMBER: 0001140361-11-020724
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110401
FILED AS OF DATE: 20110405
DATE AS OF CHANGE: 20110405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reimer Samuel R
CENTRAL INDEX KEY: 0001476156
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 11738312
MAIL ADDRESS:
STREET 1: TWO BETHESDA METRO CENTER
STREET 2: SUITE 1200
CITY: BETHESDA
STATE: MD
ZIP: 20814
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: TWO BETHESDA METRO CENTER
STREET 2: SUITE 1300
CITY: BETHESDA
STATE: MD
ZIP: 20814
BUSINESS PHONE: 3019860701
MAIL ADDRESS:
STREET 1: TWO BETHESDA METRO CENTER
STREET 2: SUITE 1300
CITY: BETHESDA
STATE: MD
ZIP: 20814
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
4
1
doc1.xml
FORM 4
X0303
4
2011-04-01
0
0000722723
HANGER ORTHOPEDIC GROUP INC
HGR
0001476156
Reimer Samuel R
10910 DOMAIN DRIVE
SUITE 300
AUSTIN
TX
78758
0
1
0
0
VP, Treasurer, Asst. Secretary
Common Stock
2011-04-01
4
S
0
1750
26.1765
D
13719
D
These shares were sold at a range of sale prices from $25.89 to $26.57. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares reported on Table I include (i) unvested restricted shares which total 3,000 shares of stock from an original grant of 3,000 shares of restricted stock made on March 25, 2011; (ii) unvested restricted shares which total 5,250 shares of stock from an original grant of 7,000 shares of restricted stock made on March 30, 2010; (iii) unvested restricted shares that total 1,250 shares of stock from an original grant of 2,500 shares of restricted stock made on November 13, 2008; (iv) unvested restricted shares and fully vested shares that total 4,069 shares of stock from an original grant of 7,000 shares of restricted stock made on June 4, 2008; and (iv) 150 shares of common stock previously purchased by the reporting person on the open market.
/s/ Teri L. Champ, Attorney-in-Fact for Samuel R. Reimer
2011-04-05